Azathioprine for pemphigus and pemphigoid--a 4 year follow-up.
D000328:Adult; D000368:Aged; D000740:Anemia / Q000139:chemically induced; D001379:Azathioprine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001859:Bone Neoplasms; D004341:Drug Evaluation; D004342:Drug Hypersensitivity; D005260:Female; D005500:Follow-Up Studies; D006400:Hematocrit; D006801:Humans; D007970:Leukopenia / Q000139:chemically induced; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D010392:Pemphigus / Q000188:drug therapy*; D011241:Prednisone / Q000009:adverse effects / Q000627:therapeutic use; D011446:Prospective Studies; D012871:Skin Diseases / Q000188:drug therapy*
D001379:Azathioprine; D011241:Prednisone